SofWave Medical Ltd.
シンボルマーク: SOFW.TA
TLV
1778
ILA今日の市場価格
-12.5902
PER(株価収益率
0.0000
PEGレシオ
607.37M
MRK キャップ
- 0.00%
DIV利回り
SofWave Medical Ltd. (SOFW-TA) 財務諸表
貸借対照表
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |||
---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 24.4 | 32 | 46.2 | ||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.net-receivables | 0 | 0 | 4.6 | 6.3 | ||||||
balance-sheet.row.inventory | 0 | 4.9 | 4 | 2 | ||||||
balance-sheet.row.other-current-assets | 0 | 0 | 1.3 | 2.6 | ||||||
balance-sheet.row.total-current-assets | 0 | 39.8 | 41.9 | 57.1 | ||||||
balance-sheet.row.property-plant-equipment-net | 0 | 3.5 | 3.8 | 3.2 | ||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0.3 | ||||||
balance-sheet.row.other-non-current-assets | 0 | 0.3 | 0.3 | 0.2 | ||||||
balance-sheet.row.total-non-current-assets | 0 | 3.8 | 4.1 | 3.6 | ||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.total-assets | 0 | 43.5 | 46.1 | 60.8 | ||||||
balance-sheet.row.account-payables | 0 | 6.3 | 3.5 | 6 | ||||||
balance-sheet.row.short-term-debt | 0 | 0.6 | 0.6 | 0.6 | ||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.long-term-debt-total | 0 | 0.8 | 1.3 | 1.8 | ||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||
balance-sheet.row.other-current-liab | 0 | 0.3 | 1.3 | 1.2 | ||||||
balance-sheet.row.total-non-current-liabilities | 0 | 0.8 | 1.3 | 2.2 | ||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.capital-lease-obligations | 0 | 1.3 | 1.9 | 2.4 | ||||||
balance-sheet.row.total-liab | 0 | 17.2 | 13.7 | 14.1 | ||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.common-stock | 0 | 0 | 0 | 66 | ||||||
balance-sheet.row.retained-earnings | 0 | -53.5 | -45.2 | -25.7 | ||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 79.8 | 77.5 | 6.4 | ||||||
balance-sheet.row.total-stockholders-equity | 0 | 26.3 | 32.3 | 46.7 | ||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 43.5 | 46.1 | 60.8 | ||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.total-equity | 0 | 26.3 | 32.3 | 46.7 | ||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||
Total Investments | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.total-debt | 0 | 1.3 | 1.9 | 2.4 | ||||||
balance-sheet.row.net-debt | 0 | -23.1 | -30.1 | -43.8 |
キャッシュフロー計算書
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -8.3 | -19.5 | -6.8 | |||||
cash-flows.row.depreciation-and-amortization | 0 | 1.5 | 1.1 | 0.4 | |||||
cash-flows.row.deferred-income-tax | 0 | 0 | 2.2 | -0.3 | |||||
cash-flows.row.stock-based-compensation | 0 | 2.3 | 5.1 | 5 | |||||
cash-flows.row.change-in-working-capital | 0 | -1.1 | 0.4 | -0.7 | |||||
cash-flows.row.account-receivables | 0 | 0 | 1.7 | -4.9 | |||||
cash-flows.row.inventory | 0 | -1.6 | -3.1 | -1.9 | |||||
cash-flows.row.account-payables | 0 | 0 | -1.7 | 4.9 | |||||
cash-flows.row.other-working-capital | 0 | 0.5 | 3.4 | 1.2 | |||||
cash-flows.row.other-non-cash-items | 0 | -0.7 | 0 | 0.4 | |||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -0.4 | -0.4 | -0.8 | |||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | |||||
cash-flows.row.purchases-of-investments | 0 | -0.1 | -0.1 | -0.2 | |||||
cash-flows.row.sales-maturities-of-investments | 0 | 0.1 | 0 | 0 | |||||
cash-flows.row.other-investing-activites | 0 | 0.8 | 0.3 | 0 | |||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 0.4 | -0.3 | -1 | |||||
cash-flows.row.debt-repayment | 0 | 0 | -0.7 | -0.2 | |||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 47 | |||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||
cash-flows.row.other-financing-activites | 0 | -1.7 | -0.7 | -0.1 | |||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -1.7 | -1.3 | 46.6 | |||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | -1.9 | 2.3 | |||||
cash-flows.row.net-change-in-cash | 0 | -7.6 | -14.2 | 43.6 | |||||
cash-flows.row.cash-at-end-of-period | 0 | 24.4 | 32 | 46.2 | |||||
cash-flows.row.cash-at-beginning-of-period | 0 | 32 | 46.2 | 2.6 | |||||
cash-flows.row.operating-cash-flow | 0 | -6.3 | -10.7 | -2.1 | |||||
cash-flows.row.capital-expenditure | 0 | -0.4 | -0.4 | -0.8 | |||||
cash-flows.row.free-cash-flow | 0 | -6.7 | -11.1 | -2.9 |
損益計算書の行
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 50.3 | 35.6 | 21.8 | |||||
income-statement-row.row.cost-of-revenue | 0 | 12.8 | 9.3 | 5.6 | |||||
income-statement-row.row.gross-profit | 0 | 37.5 | 26.3 | 16.2 | |||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||
income-statement-row.row.research-development | 0 | - | - | - | |||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.other-expenses | 0 | 0 | 0 | 0 | |||||
income-statement-row.row.operating-expenses | 0 | 45.5 | 43.7 | 25.1 | |||||
income-statement-row.row.cost-and-expenses | 0 | 58.3 | 53 | 30.7 | |||||
income-statement-row.row.interest-income | 0 | 0.8 | 0.3 | 0 | |||||
income-statement-row.row.interest-expense | 0 | 0.1 | 1.1 | 0.5 | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.total-other-income-expensenet | 0 | -0.3 | -1.9 | 1.7 | |||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0 | 0 | |||||
income-statement-row.row.total-operating-expenses | 0 | -0.3 | -1.9 | 1.7 | |||||
income-statement-row.row.interest-expense | 0 | 0.1 | 1.1 | 0.5 | |||||
income-statement-row.row.depreciation-and-amortization | 0 | 1.5 | 1.1 | 0.4 | |||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||
income-statement-row.row.operating-income | 0 | -8 | -17.3 | -8.9 | |||||
income-statement-row.row.income-before-tax | 0 | -8.3 | -19.2 | -7.1 | |||||
income-statement-row.row.income-tax-expense | 0 | 0 | 0.3 | -0.3 | |||||
income-statement-row.row.net-income | 0 | -8.3 | -19.5 | -6.8 |
よくある質問
SofWave Medical Ltd.SOFW.TA 総資産とは何ですか?
SofWave Medical Ltd. (SOFW.TA) 総資産は 43536000.000.
企業の年間売上高とは?
年間収益は N/Aである.
企業の利益率は?
利益率は 0.737 である.
企業のフリーキャッシュフローとは?
フリーキャッシュフローは -0.364.
企業の純利益率は?
純利益率は -0.300 である.
企業の総収入は?
総収入は -0.300 である.
SofWave Medical Ltd. (SOFW.TA) 純利益(純利益)とは何ですか?
純利益(純利益)は -8278000.000.
負債総額は?
負債合計は 1329000.000 である.
営業費用はいくらですか?
営業費用は 45471000.000 である.
会社の現金はいくらですか?
企業の現金は 0.000 である.